Scientists Spot Cause of Lupus, Way to Reverse It
By Dennis Thompson HealthDay Reporter
THURSDAY, July 11, 2024 -- Lupus is caused by a specific defect in the immune system that can be reversed, potentially curing the autoimmune disorder, a new study claims.
The disease appears to be caused by malfunctions in an immune system pathway that regulates cells’ response to environmental pollutants, bacteria and toxins.
Insufficient activation of this pathway, controlled by the aryl hydrocarbon receptor (AHR), results in an overproduction of immune cells that attack the body itself rather than foreign invaders, researchers said.
By fully activating this immune system response, “we can reduce the number of these disease-causing cells,” said researcher Dr. Jaehyuk Choi, an associate professor of dermatology at Northwestern University Feinberg School of Medicine.
“If these effects are durable, this may be a potential cure,” Choi added in a Northwestern news release.
Lupus occurs when the immune system turns on the body, causing systemic inflammation that can result in life-threatening damage to organs like the kidneys, heart, and brain.
Existing treatments have focused on suppressing the immune system, which left patients vulnerable to dangerous infections.
“Up until this point, all therapy for lupus is a blunt instrument. It’s broad immunosuppression,” Choi said. “By identifying a cause for this disease, we have found a potential cure that will not have the side effects of current therapies.”
To test if this pathway drives lupus, researchers tested AHR-activating drugs on blood samples taken from lupus patients.
This treatment seemed to reprogram the lupus-causing cells into cells that might instead promote wound healing, researchers reported July 10 in the journal Nature.
“We’ve identified a fundamental imbalance in the immune responses that patients with lupus make, and we’ve defined specific mediators that can correct this imbalance to dampen the pathologic autoimmune response,” researcher Dr. Deepak Rao, a rheumatologist at Brigham and Women’s Hospital in Boston, said in a news release.
The next step is to use this knowledge to make new treatments for lupus patients using AHR-activating drugs, researchers said.
Sources
- Northwestern University, news release, July 10, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Women With Autoimmune Disease At Greater Risk For Heart-Related Death
FRIDAY, May 9, 2025 — Women with common autoimmune inflammatory diseases are more likely than men to die from heart disease, a new study says. Women with rheumatoid...
Saphnelo Can Stave Off Organ Damage From Lupus
WEDNESDAY, Feb. 19, 2025 -- Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital organs through inflammation. But...
People With Lupus Are At Risk for This Type of Heart Disease
WEDNESDAY, Jan. 15, 2024 -- People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the arteries. Lupus patients with skin...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.